**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000. With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions. Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoTasso di ospedalizzazione per influenza Settimana 24, 2026?
Tasso di ospedalizzazione per influenza Settimana 24, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$4,630 Vol.
$4,630 Vol.
26 giu 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$4,630 Vol.
$4,630 Vol.
26 giu 2026
<80
$504 Vol.
No
80–85
$863 Vol.
No
85–90
$2,026 Vol.
Yes
90–95
$377 Vol.
No
95–100
$503 Vol.
No
100+
$357 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000.
With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions.
Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Mercato aperto: Jun 21, 2026, 2:07 PM ET
Volume
$4,630Data di fine
26 giu 2026Mercato aperto
Jun 21, 2026, 2:07 PM ETResolver
0x69c47De9D...Esito proposto: No
Nessuna contestazione
Esito finale: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000.
With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions.
Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$4,630Data di fine
26 giu 2026Mercato aperto
Jun 21, 2026, 2:07 PM ETResolver
0x69c47De9D...Esito proposto: No
Nessuna contestazione
Esito finale: No
**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000. With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions. Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti